Macrocyclic ghrelin receptor modulators and methods of using the same

Details for Australian Patent Application No. 2008241532 (hide)

Owner Tranzyme Pharma, Inc.

Inventors Peterson, Mark L.; Fraser, Graeme; Ouellet, Luc; Brassard, Martin; Drutz, David; Hoveyda, Hamid; Wang, Zhigang; Beauchemin, Sophie; Marsault, Eric; Benakli, Kamel

Agent Watermark

Pub. Number AU-A-2008241532

PCT Pub. Number WO2008/130464

Priority 60/889,163 09.02.07 US

Filing date 8 February 2008

Wipo publication date 30 October 2008

International Classifications

C07D 273/00 (2006.01) Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C07K 5/12 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

27 August 2009 PCT application entered the National Phase

  PCT publication WO2008/130464 Priority application(s): WO2008/130464

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008241543-Method for direct oxidation of hydrogen sulfide to elemental sulfur at low temperatures

2008241528-Novel opiate reduction utilizing catalytic hydrogen transfer reaction